Back
Novo Nordisk A/S Vs. Genmab A/S Industry Stock Comparison
Buy
74
NONOF
Novo Nordisk A/S
Last Price:
132.41
Seasonality Move:
3.75%
Sell
45
GMAB
Genmab A/S
Last Price:
29.96
Seasonality Move:
9.86%
Buy
74
Novo Nordisk A/S (NONOF)
is a Buy
Is Novo Nordisk A/S a Buy, Sell or Hold?
- The current Novo Nordisk A/S [NONOF] share price is $132.41. The Score for NONOF is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
- NONOF is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
45
Genmab A/S (GMAB)
is a Sell
Is Genmab A/S a Buy, Sell or Hold?
- The current Genmab A/S [GMAB] share price is $29.98. The Score for GMAB is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- GMAB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NONOF Stock Price Chart
What is Novo Nordisk A/S's stock price today?
-
The Novo Nordisk A/S share price today is $132.41
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NONOF is experiencing slight buying pressure.
GMAB Stock Price Chart
What is Genmab A/S's stock price today?
-
The Genmab A/S share price today is $29.98
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GMAB is experiencing buying pressure, which is a positive indicator for future bullish movement.
NONOF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.8 | Buy |
| Relative Strength Index (14 RSI): | 60.7 | Buy |
| Chaikin Money Flow: | 1155 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (123.15 - 130.13) | Buy |
| Bollinger Bands (100): | (111.29 - 130.35) | Buy |
GMAB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.16 | Buy |
| Relative Strength Index (14 RSI): | 56.17 | Buy |
| Chaikin Money Flow: | 224721 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (28.18 - 29.56) | Buy |
| Bollinger Bands (100): | (28.04 - 30.74) | Buy |
NONOF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 130.61 | Buy |
| 20-day SMA: | 127.49 | Buy |
| 50-day SMA: | 127.65 | Buy |
| 200-day SMA: | 108.43 | Buy |
| 8-day EMA: | 130.75 | Buy |
| 20-day EMA: | 128.38 | Buy |
| 50-day EMA: | 125.92 | Buy |
| 200-day EMA: | 110.08 | Buy |
GMAB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29.37 | Buy |
| 20-day SMA: | 28.86 | Buy |
| 50-day SMA: | 29.48 | Buy |
| 200-day SMA: | 31.59 | Sell |
| 8-day EMA: | 29.51 | Buy |
| 20-day EMA: | 29.2 | Buy |
| 50-day EMA: | 29.24 | Buy |
| 200-day EMA: | 31.5 | Sell |
Novo Nordisk A/S Earnings Growth & NONOF Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.52 per share, and an increase next year of $0.55 per share.
Genmab A/S Earnings Growth & GMAB Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, an increase next quarter of $0.13 per share, a decrease this year of $0.02 per share, and an increase next year of $0.47 per share.
Novo Nordisk A/S Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Genmab A/S Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||